📋 Tender Overview
Contract awarded for Rituximab lot-0001, title: pharm-2025-832 - 1, description: the market concerns the supplies of the pharmaceutical specialty containing the active ingredient 'rituximab' in a solution to be diluted for intravenous infusion (dosage: 500mg). estimated value excluding vat: 628800.00 eur.Rituximab
